ADENOSINE
Generic: ADENOSINE
Fresenius Kabi USAManufacturer
INTRAVENOUSRoute
ADENOSINEActive Substance
2005-04-27Original Approval
ADENOSINE is FDA application ANDA077133, sponsored by FRESENIUS KABI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
341 reports
2
OFF LABEL USE
106 reports
3
SUPRAVENTRICULAR TACHYCARDIA
98 reports
4
HYPOTENSION
88 reports
5
CARDIAC ARREST
79 reports
6
DYSPNOEA
74 reports
7
PAIN
70 reports
8
ATRIAL FIBRILLATION
66 reports
9
BRADYCARDIA
63 reports
10
TACHYCARDIA
62 reports